Skin cancer screening event to highlight need for early detection of the disease

MHAs and staff at the House of Assembly will have their skin checked for skin cancer by St. John's dermatologists at an event at Confederation Building, St. John's, on Tuesday April 20, 2010, from 9.30 am to 12.30pm, to raise awareness about the need for early detection of skin cancer.

Organized by the Canadian Dermatology Association, the event aims to highlight the need for early detection of skin cancer and make people aware of early warning signs of this disease.

Many skin cancers are identified by people themselves, their partners or close family members, so knowing what to look for is crucial.

Media are invited to attend the event.

- Screening dermatologists will be available for interviews - Skin cancer statistics and fact sheets on hand - Digital photos available What: Newfoundland MHAs and staff participate in skin cancer screenings and early detection awareness event hosted by St. John's dermatologists When and where: Tuesday April 20, 2010, from 9.30 am to 12.30pm, House of Assembly, Newfoundland and Labrador, 3rd Floor (Foyer outside Public Gallery), East Block, Confederation Building.

Source: CANADIAN DERMATOLOGY ASSOCIATION

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths